Benzimidazole compounds and their use as modulators of the gabaa receptor complex

Abstract From the Canadian patent

The present patent application discloses compounds having the formula (see formula I), or a pharmaceutically acceptable salt thereof or an oxide thereof wherein, R3 is, (see formula II) , wherein A, B and D each is CH, or one or two of A B and D is N and the others are, CH;~, R11 is phenyl benzimidazolyl, or monocyclic heteroaryl all of which may be substituted one or more times with substituents selected from alkyl halogen, CF3, amino, nitro, cyano, acylamino alkoxy, acyl, phenyl, and monocyclic , heteroaryl and, one of R6 and R7 is hydrogen and the other is pyrrolyl which may be substituted one or more times with substituents selected from halohen alkyl, phenyl, and alkoxy. The compounds …